{"id":254901,"date":"2018-08-17T19:00:04","date_gmt":"2018-08-17T19:00:04","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=254901"},"modified":"2018-08-17T19:00:04","modified_gmt":"2018-08-17T19:00:04","slug":"anatomic-pathology-market-2018-expected-to-surpass-22-billion-till-2022-by-top-players-global-forecast-by-mrfr","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/anatomic-pathology-market-2018-expected-to-surpass-22-billion-till-2022-by-top-players-global-forecast-by-mrfr_254901.html","title":{"rendered":"Anatomic Pathology Market 2018 Expected to Surpass $22 Billion Till 2022 by Top Players \u2013 Global Forecast by MRFR"},"content":{"rendered":"
\"\"<\/a><\/p>\n
\n
“Anatomic Pathology Market”<\/div>\n<\/div>\n<\/div>\n
Market Research Future implements an exhaustive study on Anatomic Pathology Market. This Report Cover Key Market Driver, market size, growth rate, opportunities, market Dynamics and Overall Analysis. And also cover the other information such as Anatomic Pathology Market trends, Prominent players, chapter-wise Description followed by various user perceptions and Forecast till 2022.<\/div>\n

Anatomical pathology or commonwealth is a medical specialty that is concerned with the diagnosis of disease based on the macroscopic, microscopic, biochemical, immunologic and molecular examination of organs and tissues. Anatomic pathology relays to the processing, examination, and diagnosis of surgical examples by a physician trained in pathological diagnosis. The market for anatomic pathology is growing steadily. It is expected to reach approximately USD 22 billion by the end of 2022.<\/p>\n

Get Sample PDF Illustration @ <\/em><\/strong>https:\/\/www.marketresearchfuture.com\/sample_request\/2409<\/a><\/p>\n

Key Players for Global Anatomic Pathology Market<\/strong><\/p>\n

Key players profiled in the report are Abbott Diagnostics, Agilent Technologies, Danaher, Roche Diagnostics, Thermo Fisher Scientific, Abcam, AdnaGen, Advanced Cell Diagnostics, Agendia, Angsana Molecular & Diagnostics Laboratory, AutoGenomics, Biocare Medical, Biocartis, CellMax Life, Cancer Genetics, Digipath, Enzo Biochem, Epic Sciences, Janssen Diagnostic, Monogram Biosciences, Nucleix, Omnyx, Oxford Cancer Biomarkers, RareCyte, SAKURA FINETEK USA, Tecan, and VolitionRx.<\/p>\n

Segments for Global Anatomic Pathology Market<\/strong><\/p>\n

The global anatomic pathology market is segmented on the basis of type, and application. Based on type, the market is segmented into instruments, consumable and services. Further on the basis of application the market is classified into disease diagnostic for disease such as cancer, lymphoma and others, and drug discovery and developments. Similarly market is also segmented on the basis of end users such as hospitals, clinical office laboratories, physician office laboratory and others.<\/p>\n

Regional Analysis for Global Anatomic Pathology Market<\/strong><\/p>\n

Globally North America is the largest market for anatomic pathology. Europe is the second-largest market. Furthermore Asia pacific market is expected to be the fastest growing market for anatomic pathology.<\/p>\n

Intended Audience for Global Anatomic Pathology Market<\/a>:<\/strong><\/p>\n